Cheyne Capital Management UK LLP purchased a new stake in Ultragenyx Pharmaceutical Inc. ( NASDAQ:RARE – Get Rating ) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 17,115 shares of the biopharmaceutical company's stock, valued at approximately $793,000. Ultragenyx Pharmaceutical makes up about 1.4% of Cheyne Capital Management UK LLP's portfolio, making the stock its 28th largest position.

https://www.dailypolitical.com/2023/05/21/cheyne-capital-management-uk-llp-purchases-shares-of-17115-ultragenyx-pharmaceutical-inc-nasdaqrare.html

#dailypolitical